Cognetivity Neurosciences (Cognetivity Neurosciences) Stock Based Compensation : $0.44 Mil (TTM As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Stock Based Compensation?

Cognetivity Neurosciences's Stock Based Compensation for the three months ended in Oct. 2023 was $0.02 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Oct. 2023 was $0.44 Mil.

Cognetivity Neurosciences Stock Based Compensation Historical Data

The historical data trend for Cognetivity Neurosciences's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Stock Based Compensation Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Stock Based Compensation

Get a 7-Day Free Trial

0.65

0.01

0.06

3.15

0.42

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Stock Based Compensation	Get a 7-Day Free Trial															-0.01	0.35	0.04	0.03	0.02

Cognetivity Neurosciences Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.44 Mil.

Cognetivity Neurosciences Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

1UB:Germany CGN:Canada

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

Three Companies Using AI and Innovation to Lead Healthcare Sector

By ACCESSWIRE AccessWire • 04-12-2019

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire • 04-12-2019